BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34250731)

  • 1. Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T-cell lymphomas.
    Azuma K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Ohno K; Chambers JK; Uchida K; Namba H; Nagata M; Nagamine E; Nibe K; Irie M; Tsujimoto H
    Vet Comp Oncol; 2022 Mar; 20(1):118-126. PubMed ID: 34250731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine and Feline Cutaneous Epitheliotropic Lymphoma and Cutaneous Lymphocytosis.
    Rook KA
    Vet Clin North Am Small Anim Pract; 2019 Jan; 49(1):67-81. PubMed ID: 30262145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality.
    Moore PF; Affolter VK; Graham PS; Hirt B
    Vet Dermatol; 2009 Oct; 20(5-6):569-76. PubMed ID: 20178496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
    Laprais A; Olivry T
    BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine cutaneous epitheliotropic T-cell lymphoma: a review.
    Fontaine J; Bovens C; Bettenay S; Mueller RS
    Vet Comp Oncol; 2009 Mar; 7(1):1-14. PubMed ID: 19222826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification and clinical features in 88 cases of equine cutaneous lymphoma.
    Miller CA; Durham AC; Schaffer PA; Ehrhart EJ; Powers BE; Duncan CG
    J Vet Diagn Invest; 2015 Jan; 27(1):86-91. PubMed ID: 25525142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine inflamed nonepitheliotropic cutaneous T-cell lymphoma: a diagnostic conundrum.
    Moore PF; Affolter VK; Keller SM
    Vet Dermatol; 2013 Feb; 24(1):204-11.e44-5. PubMed ID: 23331699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases.
    Fontaine J; Heimann M; Day MJ
    Vet Dermatol; 2010 Jun; 21(3):267-75. PubMed ID: 20141606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of CD20
    Ewing TS; Pieper JB; Stern AW
    Vet Dermatol; 2019 Feb; 30(1):51-e14. PubMed ID: 30474245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides).
    Brachelente C; Affolter VK; Fondati A; Porcellato I; Sforna M; Lepri E; Mechelli L; Bongiovanni L
    Vet Pathol; 2016 May; 53(3):563-6. PubMed ID: 26354309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic clinical and histopathological features of canine cutaneous epitheliotropic T-cell lymphoma.
    Dettwiler M; Mauldin EA; Jastrebski S; Gillette D; Stefanovski D; Durham AC
    Vet Pathol; 2023 Mar; 60(2):162-171. PubMed ID: 36541607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma.
    Morges MA; Burton JH; Saba CF; Vail DM; Burgess KE; Thamm DH
    J Vet Intern Med; 2014; 28(5):1569-74. PubMed ID: 25274443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004).
    Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA
    J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous epitheliotropic T-cell lymphoma with systemic dissemination in a dog.
    Mineshige T; Kawarai S; Yauchi T; Segawa K; Neo S; Sugahara G; Kamiie J; Hisasue M; Shirota K
    J Vet Diagn Invest; 2016 May; 28(3):327-31. PubMed ID: 26951331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNU in the treatment of canine epitheliotropic lymphoma.
    Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL
    J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical, morphologic and immunophenotypic data based on 10 cases of canine muco-cutaneous epidermotropic T-lymphoma (analogous to Mycosis Funcgoïde). Important of an animal model of spontaneous pathology].
    Magnol JP; Ghernati I; Marchal T; Chabanne L; Delverdier A; Fournel C
    Bull Acad Natl Med; 1996 Feb; 180(2):449-62. PubMed ID: 8705383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous epitheliotropic T-cell lymphoma in a donkey - a case report.
    Kondratjeva J; Julien F; Coutelier C; Humeau L; Moog F; Combarros D; Fourquaux I; Pressanti C; Delverdier M; Moore PF; Cadiergues MC
    BMC Vet Res; 2022 Jul; 18(1):267. PubMed ID: 35821128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015).
    Chan CM; Frimberger AE; Moore AS
    Vet Dermatol; 2018 Apr; 29(2):154-e59. PubMed ID: 28983988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clonality from multiple anatomic sites in canine epitheliotropic T cell lymphoma.
    Keating MK; Rosenkrantz WS; Keller SM; Moore PF
    Vet Dermatol; 2022 Dec; 33(6):559-567. PubMed ID: 35876313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.